| Human |
hsa_circ_RNF13 |
- |
circRNF13 |
acute myeloid leukemia |
RNF13 |
miRNA-1224-5p |
Q
| UP |
More |
| Human |
hsa_circ_RNF13 |
- |
circRNF13 |
oral mucosa leukoplakia |
RNF13 |
miR-7-5p, miR-5683, miR-7107-3p, miR-4452, miR-580-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0067717 |
circ-RNF13 |
hepatocellular carcinoma |
RNF13 |
miR-424-5p |
Q
| UP |
More |
| Human |
hsa_circ_RNF13 |
- |
circRNF13 |
nasopharyngeal carcinoma |
RNF13 |
- |
Q
H
S
| DN |
More |
| Human |
hsa_circ_RNF13 |
- |
circRNF13 |
malignant pancreatic neoplasm |
RNF13 |
miR-139-5p |
Q
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0067716 |
circ_0067716 |
lung cancer |
RNF13 |
miR-324-5p |
Q
S
| DN |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0001346 |
circRNF13 / circ-0001346 |
malignant pancreatic neoplasm |
RNF13 |
miR-654-3p |
Q
H
S
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0001346 |
circRNF13 |
cervical cancer |
RNF13 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0006801 |
circRNF13 |
oral mucosa leukoplakia |
RNF13 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0001346 |
circRNF13 |
lung cancer |
RNF13 |
miR-93-5p |
Q
| DN |
More |
| Human |
hsa_circ_RNF13 |
- |
circRNF13 |
Parkinson disease |
RNF13 |
- |
S
| DS |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0067717 |
circ‐RNF13 / cric‐RNF13 |
hepatocellular carcinoma |
RNF13 |
- |
Q
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0006801 |
circRNF13 |
oral cavity cancer |
RNF13 |
- |
Q
M
| UP |
More |
| Human |
hsa_circ_RNF13 |
- |
hsa-circRNF13 / Exo-circRNF13 |
Epstein-Barr virus-associated gastric carcinoma |
RNF13 |
hsa-miR-5683, hsa-miR-4779, miR-5683 |
Q
S
| UP |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0001346 |
circRNF13 |
lung adenocarcinoma |
RNF13 |
miR-93-5p |
Q
H
| DN |
More |
| Human |
hsa_circ_RNF13 |
hsa_circ_0067717 |
circRNA_0067717 |
nasopharyngeal carcinoma |
RNF13 |
- |
Q
H
M
| UP |
More |